OFICIAL NVIDIA Newsroom AI & Software · Jun 30, 2026

NVIDIA BioNeMo Agent Toolkit Brings Accelerated AI to Life Sciences Researchers in Claude Science

In brief · 4 sentences
Based on NVIDIA Newsroom · Jun 30, 2026

NVIDIA’s BioNeMo Agent Toolkit integrates with Anthropic’s Claude Science to provide researchers with accelerated AI workflows for genomics, proteomics, and drug discovery.

NVIDIA BioNeMo Agent Toolkit Brings Accelerated AI to Life Sciences Researchers in Claude Science
NVIDIA Newsroom — NVIDIA
Key points
·
Main topic: bioNeMo Agent Toolkit Brings Accelerated AI to Life Sciences Researchers in Claude Science.
·
Category affected: AI and software.
·
Figures mentioned: 18, 20, 2.
·
The information comes from an official source.
·
The next step is to watch availability, pricing and real-world impact.

The useful question is what changes for users, developers or buyers, and whether the announcement stays industry context or becomes something people can actually use.

NVIDIA announced the BioNeMo Agent Toolkit, designed to integrate with Anthropic’s Claude Science, an AI workbench for scientific research. The toolkit enables researchers to access NVIDIA-accelerated models and workflows directly within their natural language-driven workflows, eliminating the need for manual configuration of models or environments. This collaboration aims to streamline research processes by connecting computational tools to scientific intent through preconfigured agents. The integration supports workflows across genomics, proteomics, and drug discovery, leveraging NVIDIA’s compute resources and microservices.

The BioNeMo Agent Toolkit provides researchers with callable skills that include NVIDIA-accelerated capabilities such as Evo 2, Boltz-2, and OpenFold3. These tools enable faster execution of analyses like genomic sequence analysis, protein structure prediction, and molecular design. Scientists can describe research tasks in natural language, and the system orchestrates the workflow through domain-specialized agents. Each skill includes details about its purpose and required inputs, ensuring accurate execution and output review. The result is an iterative process where researchers refine questions and focus on scientific reasoning while computational tasks run accelerated in the background.

A practical application highlighted is the acceleration of inhibitor design for cancer targets. Researchers can start with a known antigen mutation and request potential inhibitors, with the system automating high-throughput prediction, optimization, and validation. The workflow demonstrates how AI agents can reason, plan, and use specialized computational tools to complete tasks efficiently. The BioNeMo Agent Toolkit ensures these tools operate at the speed required for scientific discovery, bridging the gap between intent and action in research environments.

The BioNeMo Agent Toolkit is open and platform-agnostic, allowing skills to work across different agent frameworks and research platforms. It is available now through NVIDIA developer resources and GitHub. Researchers can access BioNeMo-powered workflows via Anthropic’s Claude Science, which enters public beta today. Anthropic invites feedback during the beta phase to expand domain specialists and integrations based on researcher needs, further enhancing the toolkit’s utility in life sciences research.

Original source → Deals on Clipraptor.com →
Extracted signals · detected in the story
NVIDIA BioNeMo Agent Toolkit BringsAccelerated AILife Sciences ResearchersClaude Science. AnthropicClaude ScienceNVIDIA BioNeMoLifeGPU-acceleratedAnthropicNVIDIA BioNeMo Agent Toolkit18202